NCT05289388

Brief Summary

Septic shock is a life-threatening condition with mortality rate of up to -40%. Septic shock is catheterized by altered microcirculation that leads to tissue hypoperfusion and ultimately multi-organ dysfunction. Hence, maintenance of adequate tissue perfusion is the mainstay of resuscitation of patients with septic shock. Serum lactate is still considered the gold standard for evaluation of tissue perfusion. Thus, according to the latest definition, elevated serum lactate, as an indicator of tissue hypo-perfusion, is required for diagnosis of septic shock. However, lactate level change in response to resuscitation is slow even in survivors. Capillary refill time (CRT) is a simple method for assessing peripheral perfusion. Monitoring CRT was found to be a good tool for guiding resuscitation and delayed CRT showed good ability in predicting mortality in patients with septic shock. To the best of our knowledge, there is no previous report assessing the reliability of an index that include both serum lactate and CRT (lactate/CRT index) in predicting mortality in patients with septic shock. We hypothesize that the lactate/CRT index would have good accuracy in predicting mortality in patient with septic shock.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
34

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

March 13, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 21, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

March 21, 2022

Status Verified

March 1, 2022

Enrollment Period

3 months

First QC Date

March 13, 2022

Last Update Submit

March 13, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • the ability of Lactate/CRT index in predicting patient's outcome

    multiplying the CRT and serum lactate

    6 hour after admission

Secondary Outcomes (5)

  • ability of Lactate/CRT index in predicting patient's outcome

    12 hours after admission

  • ability of Lactate in predicting patient's outcome

    6 and 12 hours after admission

  • ability of CRT in predicting patient's outcome

    6 and 12 hours after admission

  • change in serum lactate

    WITHIN 1 HOUR, 6 and 12 hours after admission

  • change in CRT

    WITHIN 1 HOUR, 6 and 12 hours after admission

Interventions

Lactate/CRT indexDIAGNOSTIC_TEST

index will be calculated as the product of multiplying the CRT and serum lactate

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All consecutive patients with clinically suspected septic shock according to the latest definition of septic shock (sepsis-3) "hypotension in a patient with sepsis requiring vasopressor therapy to maintain mean arterial pressure above 65 mmHg despite adequate fluid resuscitation in addition to elevated serum lactate level (above 2 mmol/L)"

You may qualify if:

  • Patients with clinically suspected septic shock, older than 18 years old

You may not qualify if:

  • Patients less than 18 years.
  • patients with evident blood loss.
  • patients with metastatic cancer.
  • Patients with Child B or C liver cirrhosis
  • patients with estimated glomerulo filtartion rate less than 30 ml/min/m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Cairo, Egypt

Location

MeSH Terms

Conditions

Shock, Septic

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • ahmed hasanin

    Cairo University Kasr Alainy Faculty of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 13, 2022

First Posted

March 21, 2022

Study Start

March 1, 2022

Primary Completion

June 1, 2022

Study Completion

June 1, 2022

Last Updated

March 21, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

the protocol and data supporting this study will be available from the PI upon reasonable request

Locations